0000899243-22-015762.txt : 20220427 0000899243-22-015762.hdr.sgml : 20220427 20220427160527 ACCESSION NUMBER: 0000899243-22-015762 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220425 FILED AS OF DATE: 20220427 DATE AS OF CHANGE: 20220427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ambrose Kristen CENTRAL INDEX KEY: 0001856587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22859500 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001856587 Ambrose Kristen C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Chief Accounting Officer Common Stock 2022-04-25 4 S 0 60 267.37 D 3763 D Common Stock 2022-04-25 4 S 0 80 268.46 D 3683 D Common Stock 2022-04-25 4 S 0 83 269.51 D 3600 D Common Stock 2022-04-25 4 S 0 104 271.68 D 3496 D Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $267.37 (range $266.86 to $267.85). Open market sales reported on this line occurred at a weighted average price of $268.46 (range $268.05 to $268.86). Open market sales reported on this line occurred at a weighted average price of $269.51 (range $269.12 to $269.90). Open market sales reported on this line occurred at a weighted average price of $271.68 (range $271.25 to $272.23). /s/ Sabrina Yohai, Attorney-in-Fact 2022-04-27